Zurueck zur Suche

Reporte zur Charge U031360

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

16Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 4 FL 2 CA 2 NY 2 GA 2 NC 1 UT 1 MO 1 IN 1

VAERS 2596160

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

kritisch
Staat
TX
Alter
16,0
Geschlecht
M
Eingang
14.03.2023
Impfdatum
11.03.2023
Beginn
11.03.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Coma scale Fall Muscle spasms Syncope

Symptomtext

PATIENT RECEIVED THE ABOVE FULL SET OF VACCINES. UPON COMPLETION OF VACCINE ADMINISTRATION, PATIENT WAS LEAVING VACCINE ROOM WHEN HE EXPERINCED SOME DEGREE OF BODY SPASMS AND SYNCOPE, HE FELL TO THE FLOOR. PATIENT WAS IMMEDIATELY ASSISTED BY MEDICAL STAFF AND TRANSFERRED TO EXAM ROOM. PATIENT WAS ASSESSED BY SITE AND FOUND TO BE VITALLY STABLE, AAOX4, GCS 15. PATIENT STATED HE FELT FINE AND SPENT THE REST OF THE NIGHT IN OBSERVATION. PATIENT HAD A STABLE NIGHT WITHOUT ANY FURTHER INCIDENTS NOR COMPLICATIONS.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Coma scale
Hospital-Tage
-
Labordaten
FULL HEAD TO TOE ASSESSMENT BY MD ON SITE.
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2631646

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

schwer
Staat
FL
Alter
42,0
Geschlecht
M
Eingang
14.05.2023
Impfdatum
14.05.2023
Beginn
14.05.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness Syncope

Symptomtext

After receiving vaccines, patient asked for water. Before receiving water, patient passed out/or fainted. EMT's called. No physical injury and vitals within normal range. Patient expressed having needle phobia.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Patient did not disclose
Allergien
NKA
Vorherige Impfungen
-

VAERS 2521495

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

schwer
Staat
CA
Alter
1,0
Geschlecht
F
Eingang
01.12.2022
Impfdatum
01.12.2022
Beginn
01.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Seizure

Symptomtext

patient had a seizure within the hour of receiving vaccines. Mom called Drs. office, spoke with Dr. and was advised to take patient to Emergency Room.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2397639

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

schwer
Staat
CA
Alter
15,0
Geschlecht
F
Eingang
30.07.2022
Impfdatum
27.07.2022
Beginn
27.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Face injury Fall Haemorrhage Lip injury Syncope Tooth fracture Wound treatment

Symptomtext

Patient is accompanied by father and sister for vaccination, requesting four vaccines to be done at one sitting for school requirement. history of vasovagal reaction. patient was seated at the bed during vaccination with father sitting next to her. Patient was stable post vaccination. About 4-5minutes after vaccination, patient fainted and hit her face on the fall. No loss of consciousness after the fall. She had chipped her tooth from right front tooth (central incisor) with small laceration on the lower inner and outer lip. The piece of chipped tooth was intact and out of mouth. Tooth root was not exposed. Bleeding of laceration was controlled. No other injury was noted. Patient was laid flat on bed, with direct supervision and frequent vital sign check. BP96-60 HR6; BP94-60 HR72; BP96-68 HR68. Heart rate and rhythm regular. RR 16. O2sat 99-100% on room air. Bilateral radial pulses palpable. Neuro check was normal. wound was cleaned with NS and gauze. Patient was able to gargle and spit to rinse her mouth. No other oral injuries, face/head injury, joint injury noted. She was able to have a small cup of water. Father declined EMS and ED transport for further evaluation and injury. Patient was in the clinic for about 90 minutes with my direct supervision with father in the room. Patient's father connected with his friend at Fire Department and took the patient there to be evaluated. Follow up - I attempted to call for follow up on 7/27/22 at 6:24pm and 6:45 pm, 7/28/22 at 2:23pm, and 7/30/22 at 9:15am - unable to reach father/patient, unable to leave a voicemail due to voicemail box is full.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
no
Vorherige Impfungen
history of vasovagal reaction after receiving vaccines. unknown age or vaccines administered.

VAERS 2530990

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

mild
Staat
FL
Alter
16,0
Geschlecht
M
Eingang
14.12.2022
Impfdatum
12.12.2022
Beginn
13.12.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Rash

Symptomtext

The patient presented a rash over his chest, back, and both arms. No respiratory distress. He was given a Benadryl 20 mg around 04:15 pm and was then taken to the ER for further evaluation. He has been prescribed Prednisone 20 mg to be taken as follows: 2 tabs (40 mg total) PO, one time each day for 5 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2497944

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

mild
Staat
TX
Alter
1,0
Geschlecht
F
Eingang
03.11.2022
Impfdatum
03.11.2022
Beginn
03.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema

Symptomtext

About five minutes after vaccine administration, patient's mother noticed patient's left leg was noted red. Mother informed nurse and provider. Provider assessed patient and advised nurse to five 4 ml of benadryl. Nurse administered 4 ml of benadryl orally. Pt was kept in clinic for further observation. Patient's left leg redness subsided after benadryl administration and patient was discharge home with no other apparent distress.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
No Known drug or food allergies
Vorherige Impfungen
-

VAERS 2472476

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031360

mild
Staat
NY
Alter
4,0
Geschlecht
F
Eingang
07.10.2022
Impfdatum
06.10.2022
Beginn
07.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration Injection site erythema Injection site swelling Injection site warmth

Symptomtext

MMRV is supposed to be administered subcutaneously; however, my daughter had the vaccine administered intramuscularly. About 26 hours after vaccination, the injection site is very hot to the touch, red, and swollen. This covers the top 2/3 of my daughter?s upper arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2396496

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

mild
Staat
NC
Alter
1,0
Geschlecht
M
Eingang
29.07.2022
Impfdatum
12.07.2022
Beginn
19.07.2022
Tage bis Beginn
7,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Irritability Pyrexia Rash Rash erythematous Vomiting

Symptomtext

Fevers and rash 1 w after vaccines, now red bumps everywhere. Mom thinking MMR vax reaction. no current fever, just irritable. Mom does not know how high fever was, low grade per mom and some vomiting 2x in one day, none since.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2357916

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

mild
Staat
UT
Alter
30,0
Geschlecht
F
Eingang
05.07.2022
Impfdatum
28.06.2022
Beginn
01.07.2022
Tage bis Beginn
3,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Urticaria

Symptomtext

1. Allergic urticaria (L50.0). 2. Adverse effect of other viral vaccines, initial Attention not to aggravate. No formal restrictions.. first aid only encounter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
NA
Vorherige Impfungen
-

VAERS 2647367

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

gering
Staat
MO
Alter
42,0
Geschlecht
F
Eingang
20.06.2023
Impfdatum
15.06.2023
Beginn
19.06.2023
Tage bis Beginn
4,0
Dosis
UNK
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination site bruising Vaccination site induration Vaccination site mass Vaccination site swelling Vaccination site warmth

Symptomtext

Patient presented to office with vaccine site bruising to the site, skin was hard and lumpy, warm to the touch. swollen. Based off documentation from clinical staff patient was given TDAP in this arm. Patients states she was informed she was given MMR in that arm because she declined TDAP in the arm in question.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site bruising
Hospital-Tage
-
Labordaten
None that we are aware of.
Aktuelle Erkrankungen
None that we are aware of.
Vorgeschichte
None
Andere Medikamente
Vitamin D, Ferrous sulfate, omeprazole, pantoprazole, metoprolol
Allergien
NKA
Vorherige Impfungen
-

VAERS 2574418

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u031360

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
02.02.2023
Impfdatum
31.01.2023
Beginn
31.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

no additional AE; MMRII was given IM instead of subcutaneously; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, concomitant therapies and medical history was not provided. On 31-JAN-2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant Human albumin (rHA) (M-M-R II) 0.5 ml, lot #U031360, expiration date was reported as 17-OCT-2023, but upon internal review established as 07-OCT-2023, administered intramuscularly (formulation and administration site were not provided) for prophylaxis (incorrect route of product administration). No additional adverse events (AE) were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485985

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
22.10.2022
Impfdatum
13.10.2022
Beginn
13.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; improperly stored DILUENT that had a not supported TE was used to reconstitute an MMR II vaccine; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies, allergies and drug reactions were not provided. On 13-OCT-2022, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin, (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #U031360, expiration date: 07-OCT-2023, (strength, dose number, route and site of vaccination were not provided) for prophylaxis. The measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin, (M-M-R II) was reconstituted with a improperly stored, sterile diluent (STERILE DILUENT) solution for injection/infusion, 0.5 milliliter, administered once, lot #W009116, expiration date: 04-NOV-2023 (strength, route and site of administration were not provided) (product storage error). The suspect therapies underwent the temperature excursion of -23 Celsius (C) degrees for 17 hours. The previous temperature excursion did not occur. No additional adverse event (AE) (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2453578

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

gering
Staat
NY
Alter
6,0
Geschlecht
F
Eingang
21.09.2022
Impfdatum
16.09.2022
Beginn
16.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

Vaccine administration error: Child was given sister's immunizations initially, the MMR, Tdap and IPV. The nurse then, without discussion with the physician, administered a Quadracel and Hep B. Child did not receive varivax, which was ordered and will have to return for this. No adverse events or reactions documented. Counseling and follow up recommendations provided to mother by physician.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none documented
Vorgeschichte
none documented
Andere Medikamente
no medications
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2451750

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

gering
Staat
GA
Alter
-
Geschlecht
U
Eingang
20.09.2022
Impfdatum
07.09.2022
Beginn
07.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE details available; HBP in charge of vaccine storage calling for TE evaluation on refrigerated products that occurred 9/5/2022. Products were administered to multiple patients. HBP provides initials for all patients involved. Names of vaccines involved (including lot/e; This spontaneous report was received from a healthcare business professional (HBP) and refers to a patient of unknown age and gender. Concomitant therapies included sterile diluent. There was no information about the patient's concurrent conditions, drug reactions, allergies or medical history provided. On 07-SEP-2022, the patient was administered a dose of improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin [rHA]) (M-M-R II) subcutaneous injection, lot # U031360 was confirmed to be valid, with expiration date 07-OCT-2023, for prophylaxis (exact dose, route of administration and anatomical site were not provided) (product storage error). The vaccine was improperly stored for 8 hours in the temperature above 46 degrees Fahrenheit (F) (62.8 F). It was unknown if data logger was used to capture the temperature excursion. There was no previous temperature excursion. No additional adverse event details were available (no adverse event).; Sender's Comments: US-009507513-2209USA002722:02242097 US-009507513-2209USA002779:02242131 US-009507513-2209USA003021:02242077 US-009507513-2209USA002510:02242136 US-009507513-2209USA002557:02242137 US-009507513-2209USA002540:02242138 US-009507513-2209USA002566:02242139 US-009507513-2209USA002746:02242132 US-009507513-2209USA002481:02242135 US-009507513-2209USA002745:02242092 US-009507513-2209USA002570:02242096 US-009507513-2209USA002574:02242099 US-009507513-2209USA002469:02242101 US-009507513-2209USA002559:02242113 US-009507513-2209USA002573:02242103 US-009507513-2209USA002606:02242106 US-009507513-2209USA002532:02242109

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2451749

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

gering
Staat
GA
Alter
-
Geschlecht
U
Eingang
20.09.2022
Impfdatum
06.09.2022
Beginn
06.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE details available; healthcare professional in charge of vaccine storage calling for evaluation on refrigerated products that occurred 9/5/2022. Products were administered to multiple patients. Healthcare professional provides initials for all patients involved. Names of vaccines involved (including lot/e; This spontaneous report was received from a healthcare professional and refers to a patient of unknown age and gender. Concomitant therapies included sterile diluent. There was no information about the patient's concurrent conditions, drug reactions, allergies or medical history provided. On 06-SEP-2022, the patient was administered a dose of improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin [rHA]) (M-M-R II) subcutaneous injection, lot # U031360 was confirmed to be valid, with expiration date 07-OCT-2023, for prophylaxis (exact dose, route of administration and anatomical site were not provided) (product storage error). The vaccine was improperly stored for 8 hours in the temperature above 46 degrees Fahrenheit (F) (62.8 F). It was unknown if data logger was used to capture the temperature excursion. There was no previous temperature excursion. No additional adverse event details were available (no adverse event).; Sender's Comments: US-009507513-2209USA002722:02242097 US-009507513-2209USA002779:02242131 US-009507513-2209USA003055:02242082 US-009507513-2209USA002510:02242136 US-009507513-2209USA002557:02242137 US-009507513-2209USA002540:02242138 US-009507513-2209USA002566:02242139 US-009507513-2209USA002746:02242132 US-009507513-2209USA002481:02242135 US-009507513-2209USA002745:02242092 US-009507513-2209USA002570:02242096 US-009507513-2209USA002574:02242099 US-009507513-2209USA002469:02242101 US-009507513-2209USA002559:02242113 US-009507513-2209USA002573:02242103 US-009507513-2209USA002606:02242106 US-009507513-2209USA002532:02242109

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2439701

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031360

gering
Staat
TX
Alter
15,0
Geschlecht
M
Eingang
10.09.2022
Impfdatum
26.08.2022
Beginn
26.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

No reported adverse event. 2nd COVID vaccine from primary series was given on day 15 instead of waiting for 21 days as recommended by guidelines

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
Non reported
Allergien
NKDA
Vorherige Impfungen
-